Merry Life Biomedical Advances Global Phase 2 Trial of TML-6, Exploring Cellular Protein Clearance in Early Alzheimer's Disease
Global study brings together nine Taiwan medical centers, seven Swedish sites, and four U.S. centers to evaluate an oral therapy focused on autolysosomal biology TAIPEI, Sept. 21, 2026 /PRNewswire/ -- Merry Life Biomedical today announced the advancement of TML-6, a Taiwan-developed...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Greenberg Traurig Named Among BTI's 'Most Feared Law Firms in Litigation' for 2027
- La linterna de clip más vendida de Olight evoluciona: la serie Oclip 2 gira y se inclina
- La lampe à clip la plus vendue d'Olight fait peau neuve : la gamme Oclip 2 pivote et s'incline pour s'orienter là où vous en avez besoin
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →